Abstract
Blood pressure variability (BPV) may be a potentially modifiable risk factor for dementia. However, longitudinal studies investigating the associations between BPV, cerebrovascular disease (CeVD), and brain atrophy remain limited. Importantly, it is unclear whether these brain structural changes mediate the relationship between BPV and cognition, and whether such mediation effects are independent of preexisting brain pathology. This study included 362 non-demented individuals who underwent at least two neuropsychological assessments or brain magnetic resonance imaging (MRI). BPV was calculated as variation independent of mean. MRI markers of CeVD (i.e., white matter hyperintensity [WMH], lacunes, cerebral microbleeds [CMBs], intracranial stenosis, and cortical infarcts) and brain atrophy (i.e., white matter volume [WMV], gray matter volume [GMV], and lateral ventricular volume [VV]), were evaluated. Plasma p-tau181 was measured as a marker of amyloid pathology. Higher systolic BPV (SBPV) was associated with worse cognitive outcomes. SBPV was associated with WMH, cortical infarcts, and VV at the final brain MRI. These results were consistent in longitudinal analyses. The association between SBPV and cognition was partially mediated by CeVD and brain atrophy, with mediation proportion ranging from 17 to 24% for CeVD and 14 to 35% for brain atrophy. Preexisting CeVD and amyloid pathology had minimal influence on these mediation effects. SBPV showed stronger effects than other BPV indices on cognition, CeVD, and brain atrophy.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


References
van Dalen JW, Brayne C, Crane PK, Fratiglioni L, Larson EB, Lobo A, et al. Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality. JAMA Intern Med. 2022;182:142–52.
Gyanwali B, Cai CXT, Chen C, Vrooman H, Tan CS, Hilal S. The effects of mean of visit-to-visit blood pressure on incident brain vascular lesions and functional-cognitive decline. J Alzheimers Dis. 2021;82:561–73.
Ma Y, Blacker D, Viswanathan A, van Veluw SJ, Bos D, Vernooij MW, et al. Visit-to-visit blood pressure variability, neuropathology, and cognitive decline. Neurology. 2021;96:e2812–e23.
Alpérovitch A, Blachier M, Soumaré A, Ritchie K, Dartigues JF, Richard-Harston S, et al. Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study. Alzheimers Dement. 2014;10:S330–7.
Rouch L, Cestac P, Sallerin B, Piccoli M, Benattar-Zibi L, Bertin P, et al. Visit-to-visit blood pressure variability is associated with cognitive decline and incident dementia: the S.AGES Cohort. Hypertension. 2020;76:1280–8.
de Havenon A, Anadani M, Prabhakaran S, Wong KH, Yaghi S, Rost N. Increased blood pressure variability and the risk of probable dementia or mild cognitive impairment: a post hoc analysis of the SPRINT MIND Trial. J Am Heart Assoc. 2021;10:e022206.
Tully PJ, Yano Y, Launer LJ, Kario K, Nagai M, Mooijaart SP, et al. Association between blood pressure variability and cerebral small-vessel disease: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9:e013841.
Li X, Hui Y, Shi H, Li R, Lv H, Wu Y, et al. Gray matter volume mediates the association of long-term blood pressure variability with cognitive function in an adult population. Alzheimers Dement. 2024;20:4476–85.
Haring B, Liu J, Salmoirago-Blotcher E, Hayden KM, Sarto G, Roussouw J, et al. Blood pressure variability and brain morphology in elderly women without cardiovascular disease. Neurology. 2019;92:e1284–e97.
Sabayan B, Wijsman LW, Foster-Dingley JC, Stott DJ, Ford I, Buckley BM, et al. Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ. 2013;347:f4600.
Ma Y, Tully PJ, Hofman A, Tzourio C. Blood pressure variability and dementia: a state-of-the-art review. Am J Hypertens. 2020;33:1059–66.
Li Q, Su S, Feng Y, Jia M, Zhan J, Liao Z, et al. Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer’s disease and cerebral small vessel disease. Alzheimers Dement. 2024;20:4891–902.
Xu X, Hilal S, Collinson SL, Chong EJ, Ikram MK, Venketasubramanian N, et al. Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition. Stroke. 2015;46:2808–14.
Takahashi H, Saito K, Yakura N. Validation of Omron HEM-9200T, a home blood pressure monitoring device for the upper arm, according to the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 81060-2:2013 protocol. J Hum Hypertens. 2022;36:416–9.
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens. 2012;30:1556–63.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.
Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.
Hilal S, Saini M, Tan CS, Catindig JA, Dong YH, Holandez RL, et al. Intracranial stenosis, cerebrovascular diseases, and cognitive impairment in chinese. Alzheimer Dis Assoc Disord. 2015;29:12–7.
Zhao L, Luo Y, Mok V, Shi L. Automated brain volumetric measures with AccuBrain: version comparison in accuracy, reproducibility and application for diagnosis. BMC Med Imaging. 2022;22:117.
Guo C, Niu K, Luo Y, Shi L, Wang Z, Zhao M, et al. Intra-scanner and inter-scanner reproducibility of automatic white matter hyperintensities quantification. Front Neurosci. 2019;13:679.
Shi L, Wang D, Liu S, Pu Y, Wang Y, Chu WC, et al. Automated quantification of white matter lesion in magnetic resonance imaging of patients with acute infarction. J Neurosci Methods. 2013;213:138–46.
Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–9.
Prins ND, van Straaten EC, van Dijk EJ, Simoni M, van Schijndel RA, Vrooman HA, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology. 2004;62:1533–9.
Gyanwali B, Shaik MA, Tan BY, Venketasubramanian N, Chen C, Hilal S. Risk factors for and clinical relevance of incident and progression of cerebral small vessel disease markers in an Asian memory clinic population. J Alzheimers Dis. 2019;67:1209–19.
Chong JR, Ashton NJ, Karikari TK, Tanaka T, Saridin FN, Reilhac A, et al. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer’s disease patients with concomitant cerebrovascular disease. Alzheimers Dement. 2021;17:1649–62.
Xu X, Chan QL, Hilal S, Ikram MK, Venketasubramanian N, Tan BY, et al. The diagnostic utility of the NINDS-CSN neuropsychological battery in memory clinics. Dement Geriatr Cogn Dis Extra. 2016;6:276–82.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–4.
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–41.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Vol 4. Washington: American Psychiatric Association; 1994.
Kleiber C, Zeileis A. Applied econometrics with R. https://doi.org/10.1007/978-0-387-77318-6). New York: Springer; 2008.
Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation: R package for causal mediation analysis. J Stat Softw. 2014;59:1–38.
Ma, Wolters Y, Chibnik FJ, Licher LB, Ikram MA S, Hofman A, et al. Variation in blood pressure and long-term risk of dementia: a population-based cohort study. PLoS Med. 2019;16:e1002933.
de Heus RAA, Tzourio C, Lee EJL, Opozda M, Vincent AD, Anstey KJ, et al. Association between blood pressure variability with dementia and cognitive impairment: a systematic review and meta-analysis. Hypertension. 2021;78:1478–89.
Hilal S, Biesbroek JM, Vrooman H, Chong E, Kuijf HJ, Venketasubramanian N, et al. The impact of strategic white matter hyperintensity lesion location on language. Am J Geriatr Psychiatry. 2021;29:156–65.
Obler LK, Rykhlevskaia E, Schnyer D, Clark-Cotton MR, Spiro A 3rd, et al. Bilateral brain regions associated with naming in older adults. Brain Lang. 2010;113:113–23.
Daniel GD, Chen H, Bertoni AG, Hughes TM, Hayden KM. High visit-to-visit blood pressure variability predicts global cognitive decline: the Multi-Ethnic Study of Atherosclerosis. Alzheimers Dement. 2022;8:e12342.
Ogliari G, Smit RA, Westendorp RG, Jukema JW, de Craen AJ, Sabayan B. Visit-to-visit blood pressure variability and future functional decline in old age. J Hypertens. 2016;34:1544–50.
Sun F. The impact of blood pressure variability on cognition: current limitations and new advances. J Hypertens. 2023;41:888–905.
Ma Y, Song A, Viswanathan A, Blacker D, Vernooij MW, Hofman A, et al. Blood pressure variability and cerebral small vessel disease: a systematic review and meta-analysis of population-based cohorts. Stroke. 2020;51:82–9.
Ma, Yilmaz Y, Bos P, Blacker D, Viswanathan D, Ikram MA A, et al. Blood pressure variation and subclinical brain disease. J Am Coll Cardiol. 2020;75:2387–99.
Morrison C, Oliver MD, Kamal F, Dadar M. Beyond hypertension: examining variable blood pressure’s role in cognition and brain structure. J Gerontol B Psychol Sci Soc Sci. 2024;79:gbae121.
Lattanzi S, Brigo F, Vernieri F, Silvestrini M. Visit-to-visit variability in blood pressure and Alzheimer’s disease. J Clin Hypertens. 2018;20:918–24.
Tedla YG, Yano Y, Carnethon M, Greenland P. Association between long-term blood pressure variability and 10-year progression in arterial stiffness: the multiethnic study of atherosclerosis. Hypertension. 2017;69:118–27.
Diaz KM, Veerabhadrappa P, Kashem MA, Thakkar SR, Feairheller DL, Sturgeon KM, et al. Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans. J Hum Hypertens. 2013;27:671–7.
Xuereb RA, Magri CJ, Xuereb RG. Arterial stiffness and its impact on cardiovascular health. Curr Cardiol Rep. 2023;25:1337–49.
Badji A, Sabra D, Bherer L, Cohen-Adad J, Girouard H, Gauthier CJ. Arterial stiffness and brain integrity: a review of MRI findings. Ageing Res Rev. 2019;53:100907.
Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev. 2014;15:16–27.
Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41–53.
Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806–12.
McKenzie JA, Spielman LJ, Pointer CB, Lowry JR, Bajwa E, Lee CW, et al. Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases. Curr Aging Sci. 2017;10:158–76.
Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res. 2008;31:2137–46.
Sible IJ, Nation DA. Long-term blood pressure variability across the clinical and biomarker spectrum of Alzheimer’s disease. J Alzheimers Dis. 2020;77:1655–69.
Nagai M, Sible IJ, Tully PJ, Po SS, Dasari TW. The effect of visit-to-visit blood pressure variability on cognitive function: state-of the-art. Cereb Circ Cogn Behav. 2025;9:100392.
Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906–15.
Tully PJ, Dartigues JF, Debette S, Helmer C, Artero S, Tzourio C. Dementia risk with antihypertensive use and blood pressure variability: a cohort study. Neurology. 2016;87:601–8.
Mahinrad S, Bennett DA, Sorond FA, Gorelick PB. Blood pressure variability, dementia, and role of antihypertensive medications in older adults. Alzheimers Dement. 2023;19:2966–74.
Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965–82.
Acknowledgements
We sincerely thank the patients and their families for participating in this study. We also thank the clinical and research operations team, the neuropsychometric rating team, and the administrative staff of the Memory, Ageing, and Cognition Centre for their invaluable support in participant recruitment and assessments.
Funding
This work was supported by National Medical Research Council of Singapore, Translational Research Investigator Award (MOH-000707-00), National Medical Research Council of Singapore (NMRC/CIRG/1485/2018 and NMRC/CIRG/1446/2016), and National Medical Research Council of Singapore, Senior Clinician Scientist Award (NMRC/CSA-SI/0007/2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cui, J., Robert, C., Toh, A.Q. et al. Visit-to-visit blood pressure variability, brain MRI measures, and cognition in non-demented older adults. Hypertens Res (2025). https://doi.org/10.1038/s41440-025-02435-1
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41440-025-02435-1